The governed asset case, from TPP to rNPV
Turn scientific promise into value you can defend.
Pixen connects your target product profile, competitive position, forecast and risk-adjusted value in one governed case, so every decision about your asset holds up in the boardroom, the partnering meeting and the data room.
Evidence is everywhere.
Conviction is scarce.
Research tools, intelligence databases and real-world data now give biopharma teams more evidence than ever. What they don't give you is a decision your whole business, your board and your partners will stand behind. An asset's value is decided in the space between the evidence and the approval. That is where Pixen works.
Value
What Pixen does for your asset
Prove what your asset is worth.
A risk-adjusted value built line by line from sourced assumptions, ready for the board, the partner and the data room.
Prove value → 02Know where you win.
Differentiation scored against your own target profile, not asserted, and kept current as the market moves.
Know where you win → 03Decide with confidence, together.
One governed case that clinical and commercial both sign, so decisions are made once and stay made.
Decide together →Change the profile.
See the value.
In Pixen, your target product profile, competitive position, forecast and rNPV are one connected case. Tighten an endpoint, and you see what it does to your differentiation, your forecast and what the asset is worth, with every step sourced and approved.
Target profile
Competitive position
Forecast
Risk-adjusted value
Inside Pixen
The same case, four ways in
Screens from an illustrative tenant, rebuilt live. Click, switch and hover: each one responds.
Who it's for
Built for the decisions that define your business
Before the readout, the round or the partnering meeting.
Clinical-stage biotech
Walk in with a case that holds up.
Explore →Before the next stage gate or portfolio review.
Mid-size pharma
Put capital behind the assets that earn it.
Explore →Before you commit.
Investors and BD Teams
Diligence an asset case you can trace.
Explore →In depth
Decision-grade depth
One illustrative asset, modelled end to end: from eligible patients to a risk-adjusted value.Illustrative data
Open
Bring your evidence. Keep your stack.
Pixen does not ask you to replace your research tools, data sources or consultants. It is where their output becomes an approved decision about your asset. Import population data with templates today, and export every approved case to Excel and PDF.
- Evidence connectors
- Microsoft 365 and Teams access
- Hand-off to execution systems